Topic: contract manufacturer
Pennsylvania-based Recro Pharma has expanded its CDMO manufacturing, adding a 24,000-square-foot facility that includes high-potent processing.
If the German contract manufacturer delivers all projects over the 10-year course, it could receive up to $80 million.
Here is some news of note for the week.
U.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees.
Here is some other pharma manufacturing news of note for the week.
Cambrex finalizes $425 million acquisition of dosage-form CDMO Halo Pharma and its two manufacturing plants.
Teva will shift production from a plant in Ashdod, Israel, to a contract manufacturer when it closes early next year.
Korean CDMO Samsung BioLogics has won FDA approval for its first finished product at the second of three plants built in rapid succession.
Cambrex has negotiated a $425 million deal to buy Halo Pharma, picking up two manufacturing facilities in the process.
Foshan Jinxiong Technology has been on an import alert list since February, banning all of its products from entering the U.S.